[CAS NO. 312917-14-9]  JNK Inhibitor IX

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [312917-14-9]

Store
Catalog
SLK-S7508
Brand
Selleck
CAS
312917-14-9

DESCRIPTION [312917-14-9]

Overview

MDLMFCD01005305
Molecular Weight332.42
Molecular FormulaC20 H16 N2 O S
SMILESO=C(NC1=C(C#N)C(CCCC2)=C2S1)C3=C4C=CC=CC4=CC=C3

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM3.0082 mL15.0412 mL30.0824 mL
5 mM0.6016 mL3.0082 mL6.0165 mL
10 mM0.3008 mL1.5041 mL3.0082 mL
50 mM0.0602 mL0.3008 mL0.6016 mL

Description

JNK inhibitor IX (TCS JNK 5a) is a selective and potent inhibitor with of 6.5 and 6.7 for JNK2 and JNK3, respectively.

Targets

JNK3 [1]JNK2 [1]
6.7(pIC50)6.5(pIC50)

In vitro

JNK inhibitor IX significantly reduces caspase-3 activity by the inhibition of JNK activity in human dermal fibroblasts. JNK inhibition by JNK inhibitor IX significantly increases apoptotic death in response to imatinib mesylate (IM) by preventing c-ABL complete de-phosphorylation at Ser residues.